|1.||Mei, Wenjie: 1 article (04/2014)|
|2.||Lin, Yongpeng: 1 article (04/2014)|
|3.||Du, Yanxin: 1 article (04/2014)|
|4.||Zhang, Hu: 1 article (04/2014)|
|5.||Li, Hong: 1 article (04/2014)|
|6.||Chen, Bolai: 1 article (04/2014)|
|7.||Fu, Xiaoyan: 1 article (04/2014)|
|8.||Chen, Tianfeng: 1 article (04/2014)|
|9.||Ning, Feipeng: 1 article (04/2014)|
|10.||Guo, Yuhai: 1 article (04/2014)|
09/15/2011 - "Among the compounds, trifluoromethane-containing 1,2,4-triazoles possessed the five-membered ring groups on the C-5 position of the triazolic ring, including cyclopentyl, 3-furyl, 3-thienyl, and 2-pyrrolyl, possessed the significant inhibitory activity for NCI-H226 cancer cells."
09/15/2011 - "Their growth inhibitory results against cancer cells indicated that some of the fluorine- and trifluoromethane-containing compounds could effectively inhibit the growth of NCI-H226 and T-cell leukemia (Jurkat) cells. "
04/01/2014 - "The results showed that ruthenium polypyridyl complexes, especially [Ru(bpy)2 (p-tFPIP)](2+) (2 a; bpy=bipyridine, tFPIP=2-(2-trifluoromethane phenyl)imidazole[4,5-f][1,10]phenanthroline), exhibited novel anticancer activity against human cancer cell lines, but with less toxicity to a human normal cell line. "
|3.||Cardiac Arrhythmias (Arrythmia)
|4.||T-Cell Leukemia (Leukemia, T Cell)